General MedicationsINJECTIONStandard
HERCESSI
TRASTUZUMAB-STRF
Standard Dose
150MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary
Approval overview HERCESSI is listed in Drugs@FDA under application 761346 (BLA).
Review priority: N/A Marketing status: Prescription Active ingredient TRASTUZUMAB-STRF Form and strength INJECTABLE;INJECTION - 150MG Sponsor ACCORD BIOPHARMA INC.
Structured Monograph
Clinical summary
Approval overview HERCESSI is listed in Drugs@FDA under application 761346 (BLA). Review priority: N/A Marketing status: Prescription Active ingredient TRASTUZUMAB-STRF Form and strength INJECTABLE;INJECTION - 150MG Sponsor ACCORD BIOPHARMA INC. Submission history Latest submission status date: 2024-09-06 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: N/A
Interaction Notes
- No interaction notes stored yet.